A new class of arylsulfonylcarbamoyl-1,3-cyclohexanediones and arylsulfonylcarbamoyl-1,3-dicarbonylacyclic compounds are disclosed. These substances have hypoglycemic or hyperglycemic properties and are of value in controlling abnormal blood sugar levels. The arylsulfonylcarbamoyl derivatives of 1,3-dicarbonylalicyclic and acyclic compounds are prepared by reacting an arylsulfonylisocyanate with a 1,3-dicarbonylalicyclic or acyclic reactant. Typical embodiments are 2-(N-p-chlorobenzenesulfonylcarbamoyl)-5,5-dimethylcyclohexane-1,3-dione and 5-(1-ethylpropyl)-2-(N-p-chlorobenzenesulfonylcarbamoyl)-1,3-cyclohexanedi one.
一类新的芳基磺酰
脲基-
1,3-环己二酮和芳基磺酰
脲基-1,3-二羰基环状化合物被公开。这些物质具有降血糖或升血糖的性质,在控制异常血糖
水平方面具有价值。通过将芳基磺酰
异氰酸酯与1,3-二羰基环状或非环状反应物反应,制备了1,3-二羰基环状和非环状化合物的芳基磺酰
脲衍
生物。典型的实施例包括2-(N-对
氯苯磺酰
脲基)-5,5-二
甲基环己烷-1,3-二酮和5-(1-乙基丙基)-2-(N-对
氯苯磺酰
脲基)-
1,3-环己二酮。